Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: A randomized controlled trial

John H. Alexander, Gail Hafley, Robert A. Harrington, Eric D. Peterson, T. Bruce Ferguson, Todd J. Lorenz, Abhinav Goyal, Michael Gibson, Michael J. Mack, Daniel Gennevois, Robert M. Califf, Nicholas T. Kouchoukos

Research output: Contribution to journal › Article › peer-review